South Dakota’s medical cannabis program stands at a critical juncture following the federal partial rescheduling of certain marijuana products to Schedule III.¹ After the DEA’s June 29, 2026 rescheduling hearing concludes, the undersigned will formally petition the South Dakota Department of Health (DOH) to review and align the state’s Schedule I classification of marijuana with … Continue reading Advance Notice to South Dakota Department of Health: Petition for Scheduling Review Will Follow Federal Rescheduling Hearings